Financials: Hikma Pharmaceuticals PLC (HIK.L)

HIK.L on London Stock Exchange

1,809.92GBp
4:49am EDT
Price Change (% chg)

-4.00p (-0.22%)
Prev Close
1,814.00p
Open
1,816.00p
Day's High
1,817.00p
Day's Low
1,806.00p
Volume
21,632
Avg. Vol
237,194
52-wk High
1,835.00p
52-wk Low
1,000.61p

Search Stocks

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-14 10 1,450.36 1,526.64 1,385.00 1,353.66
Year Ending Dec-15 10 1,571.05 1,681.99 1,431.35 1,500.03
EARNINGS (per share)
Year Ending Dec-14 11 1.23 1.36 1.04 0.88
Year Ending Dec-15 11 1.27 1.51 1.00 0.99
LT Growth Rate (%) 2 15.30 28.80 1.80 20.75

Sales and Earnings Figures in U.S. Dollars (USD)

Valuation Ratios

  Company Industry Sector
P/E Ratio (TTM) 28.74 35.65 36.07
P/E High - Last 5 Yrs. 25.12 39.41 40.27
P/E Low - Last 5 Yrs. 18.54 13.26 14.11
Beta 0.82 0.82 0.81
Price to Sales (TTM) 4.48 4.65 5.51
Price to Book (MRQ) 6.00 6.82 6.69
Price to Tangible Book (MRQ) 10.73 9.58 9.42
Price to Cash Flow (TTM) 21.82 28.56 28.22
Price to Free Cash Flow (TTM) 27.42 6.74 10.90
% Owned Institutions -- -- --

Dividends

  Company Industry Sector
Dividend Yield 0.68 1.46 1.43
Dividend Yield - 5 Year Avg. 1.17 1.56 1.53
Dividend 5 Year Growth Rate 21.67 31.08 29.90
Payout Ratio(TTM) 18.68 14.75 15.52

Growth Rates

  Company Industry Sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 26.00 15.25 15.53
Sales (TTM) vs TTM 1 Yr. Ago 23.08 15.09 15.13
Sales - 5 Yr. Growth Rate 18.64 12.77 12.74
EPS (MRQ) vs Qtr. 1 Yr. Ago 133.62 8.81 13.21
EPS (TTM) vs TTM 1 Yr. Ago 112.30 -- --
EPS - 5 Yr. Growth Rate 29.35 16.02 15.77
Capital Spending - 5 Yr. Growth Rate 2.74 21.25 20.52

Financial Strength

  Company Industry Sector
Quick Ratio (MRQ) 1.06 2.11 2.10
Current Ratio (MRQ) 1.53 3.06 3.07
LT Debt to Equity (MRQ) 27.73 5.38 6.97
Total Debt to Equity (MRQ) 43.46 12.30 13.85
Interest Coverage (TTM) 4.66 22.37 21.22

Profitability Ratios

  Company Industry Sector
Gross Margin (TTM) 55.97 54.07 53.58
Gross Margin - 5 Yr. Avg. 48.85 53.37 53.07
EBITD Margin (TTM) 33.86 -- --
EBITD - 5 Yr. Avg 25.43 19.73 18.79
Operating Margin (TTM) 24.62 13.52 10.94
Operating Margin - 5 Yr. Avg. 18.15 16.08 14.83
Pre-Tax Margin (TTM) 21.83 13.21 10.44
Pre-Tax Margin - 5 Yr. Avg. 15.54 16.33 15.08
Net Profit Margin (TTM) 15.82 9.33 6.58
Net Profit Margin - 5 Yr. Avg. 12.30 12.15 10.90
Effective Tax Rate (TTM) 27.52 24.56 24.88
Effective Tax Rate - 5 Yr. Avg. 20.87 25.14 25.63

Efficiency

  Company Industry Sector
Revenue/Employee (TTM) -- 984,060,890 920,489,556
Net Income/Employee (TTM) -- 116,812,680 109,172,693
Receivable Turnover (TTM) 3.72 6.71 6.67
Inventory Turnover (TTM) 2.19 2.94 3.91
Asset Turnover (TTM) 0.75 1.19 1.16

Management Effectiveness

  Company Industry Sector
Return on Assets (TTM) 11.81 14.31 4.90
Return on Assets - 5 Yr. Avg. 8.49 14.92 14.32
Return on Investment (TTM) 16.78 18.91 18.18
Return on Investment - 5 Yr. Avg. 11.49 19.95 19.14
Return on Equity (TTM) 22.92 19.67 19.05
Return on Equity - 5 Yr. Avg. 14.81 20.54 19.81
  1 Year 3 Years 5 Years
Sales % 23.08 23.15 18.64
EPS % 112.00 28.71 29.35
Dividend % 25.00 15.44 21.67
Note: Units in Millions of US Dollars

Performance for Hikma Pharmaceuticals PLC

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 7.33 6.89 74 74
13 Week 15.89 14.92 62 53
26 Week 53.38 48.84 73 62
52 Week 67.01 60.54 68 47
YTD 50.19 49.97 72 82
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 50.57%
# of Holders: 201
Total Shares Held: 100,387,370
3 Mo. Net Change: -13,632
# New Positions: 7
# Closed Positions: 4
# Increased Positions: 55
# Reduced Positions: 50
# Net Buyers: 5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Search Stocks